Safety

Benzisothiazolinone: Allergy, Toxicity & Environmental Impact — A Factual Review

Responsible use of any industrial biocide requires understanding its human health and environmental profile alongside its performance benefits. This page summarises the documented occupational allergy, aquatic toxicity, and regulatory status data for Benzisothiazolinone (BIT) based on published toxicological literature and EU regulatory decisions.

Published 2026-01-15Updated 2026-07-27By Vasudev Chemo Pharma Technical TeamReviewed by Vasudev Chemo Pharma EHS & Quality Team, Industrial Safety, GHS Classification

Is Benzisothiazolinone a Known Skin Allergen?

Yes. Benzisothiazolinone is documented in dermatological literature as both an irritant and a contact allergen, with occupational allergic contact dermatitis reported in paint manufacturing, printing, pottery mould-making, and rubber processing among workers handling BIT-containing materials.

This sensitisation risk is why concentrated BIT 20% carries hazard statement H317 (may cause an allergic skin reaction) in addition to its corrosivity classification, and why standard PPE — gloves, eye protection — is essential when handling the concentrated product directly. Finished formulations at typical use dilutions present a substantially lower exposure risk than the raw concentrate, but sensitised individuals may still react to trace residual levels; this is a known characteristic of the isothiazolinone class generally, not unique to BIT.

Is Benzisothiazolinone Toxic to Aquatic Life?

Yes. Published ecotoxicology data documents inhibitory effects on several algae species at low milligram-per-litre concentrations, and concentrated BIT products carry GHS aquatic toxicity classification (typically H400/H411), reflecting toxicity to aquatic organisms and long-lasting environmental effects.

The primary mechanism of toxicity to algae in laboratory studies is linked to disruption of photosynthetic systems. This aquatic toxicity underlies the specific handling guidance to prevent the concentrated product or contaminated wash-water from entering drains, waterways, or soil. Regulatory bodies including the US EPA and the European Chemicals Agency have reviewed benzisothiazolinone's environmental profile as part of the EU Biocidal Products Regulation assessment that led to its approval for product-types 6 and 13 in May 2025; that assessment weighs both hazard properties and realistic exposure scenarios for each approved use.

Does Benzisothiazolinone Biodegrade in the Environment?

Some published assessments describe relatively rapid biodegradation for benzisothiazolinone under certain test conditions, with correspondingly limited persistence reported. Environmental fate findings vary by test methodology and environmental compartment, so consult the current SDS for authoritative data on a specific product.

Environmental fate assessments can vary depending on the specific test methodology, environmental compartment (water, soil, sediment), and regional regulatory framework applied — buyers with specific environmental compliance requirements should consult the current SDS and any regulatory dossier documentation available from their supplier rather than relying on a single generalised statement. Overall eco-risk assessment for any biocide, including BIT, weighs both intrinsic hazard properties (toxicity, persistence) and the realistic likelihood and scale of environmental exposure given the specific application and handling practices — a chemical used in a fully enclosed industrial process with proper wastewater treatment presents a different real-world risk profile than the same chemical used in an application with a higher likelihood of direct environmental release.

What Is the Current Regulatory Status of Benzisothiazolinone?

The European Commission approved BIT as an existing active substance for biocidal product-types 6 (in-can preservative) and 13 (metalworking fluid preservative) under Implementing Regulation (EU) 2025/929, published May 2025. Cosmetic use limits are governed separately under the EU Cosmetic Regulation and CosIng database.

Because regulatory status, permitted concentration limits, and classification details are subject to periodic revision, always consult the current Safety Data Sheet and any applicable regulatory registration documentation for your specific product and target market rather than relying on general summaries such as this one for compliance decisions.

Benzisothiazolinone hazard and regulatory summary
Aspect	Status / classification
Skin/eye hazard (concentrate)	Corrosive, GHS05, H314 (severe skin burns/eye damage)
Sensitisation	H317 (may cause an allergic skin reaction); documented occupational contact dermatitis
Aquatic toxicity	H400/H411 (very toxic to aquatic life / long-lasting effects)
EU BPR status	Approved for product-types 6 and 13 — Implementing Regulation (EU) 2025/929, May 2025

Frequently asked questions

Is Benzisothiazolinone a known skin allergen?+

Yes. BIT is documented in toxicological literature as a skin sensitiser, with occupational contact dermatitis reported across several industries handling the concentrated substance or BIT-containing process fluids. Standard PPE is essential when handling the concentrate.

Is Benzisothiazolinone toxic to fish and aquatic life?+

Concentrated BIT products carry GHS aquatic toxicity classification (typically H400/H411), and published ecotoxicology studies have documented inhibitory effects on some algae species at low concentrations. Prevent concentrated product or wash-water from entering waterways.

Does Benzisothiazolinone biodegrade in the environment?+

Some published assessments report relatively rapid biodegradation under certain test conditions with limited persistence concern, though findings vary by test methodology. Consult the current SDS for authoritative environmental fate data on your specific product.

Is Benzisothiazolinone approved under EU biocide regulations?+

Yes. The European Commission approved 1,2-Benzisothiazol-3(2H)-one (BIT) for biocidal product-types 6 and 13 under Implementing Regulation (EU) 2025/929, published May 2025.